These studies indicate that lung adenocarcinoma cells, but not normal lung epithelial cells, are primed to respond to IL-1 signaling by inducing the expression of cytoprotective immune checkpoint proteins, which could promote tumor cell survival through immunosuppression. Here, IL1A is linked to neoplasm.